Close
Description
A greater understanding of the biology of cancer has led to the development of specifically targeted interventions and advanced therapies (gene, cell and tissues) to treat cancer, and to the possibility of personalised (also called stratified or precision) medicine which is impacting on cancer trial methodology.
This module will provide you with knowledge of the development pathway for new cancer interventions, from first-in-man studies to licensed product, through to clinical practice. You will learn about the different phases of cancer clinical trials and the main design and practical issues associated with conducting, interpreting and reporting cancer trials. You will receive grounding in how these complex and closely regulated studies are performed by researchers active in, and at the forefront of, the field, and you will gain an appreciation of how to interpret clinical trial data and recognise their limitations. You will also understand some of the regulatory policies and processes required to ensure the ethical nature, legal compliance and quality assurance of clinical trials. Although the focus is on cancer trials the skills gained are transferable to other disease areas.
Module deliveries for 2024/25 academic year
Last updated
This module description was last updated on 8th April 2024.
听